• Kyodo

  • SHARE

A research team that includes a Japanese professor at the University of Chicago has shown that a drug being developed in Japan can eradicate lung cancer cells, according to a study published in the U.S. medical journal Science Translational Medicine.

According to the study, the research team found that the drug, which is called OTS964 and is being developed by a startup company outside of Tokyo, helped eliminate human lung cancer tumors transplanted into mice, by inhibiting the activity of a specific protein.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)